The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003
- PMID: 16909413
- DOI: 10.1002/cncr.22126
The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003
Abstract
Background: Cutaneous melanoma (CM) incidence and mortality have risen dramatically during the past 2 generations, particularly among Caucasian populations. Detailed, long-term trends of CM in relation to clinical and pathologic characteristics in a Central European population have not been published to date.
Methods: The current study was based on 1980 patients with invasive CM diagnosed in Southern Germany during the years from 1976 to 2003 documented by the Central Malignant Melanoma Registry. The German standard population was used to calculate age-standardized rates, and the annual percent change was estimated by using age, anatomic site, histologic type, and tumor thickness.
Results: During the study period, the incidence of CM approximately was tripled for males and females, reaching 10.3 and 13.3 per 100,000 per year, respectively (P < .001). The largest increases occurred for melanoma localized on the upper limbs (annual change, 5.9% for males and 5.0% for females; P < .001) and superficially spreading melanoma (annual change, 7.8% for males and 5.9% for females; P < .001). Thin tumors (Breslow thickness <1 mm) were presented significantly more often during the study period (annual change, 9.8% for males and 6.1% for females; P < .001), predominantly in younger patients. Thick tumors and nodular melanomas were more frequent among older patients (age >70 years), particularly among males. The age-standardized mortality decreased from 1.5 to 0.8 per 100,000 males and from 2.6 to 0.8 per 100,000 females with a significant downward trend for the female population (P < .001).
Conclusions: The current results indicated which diverging trends between incidence and mortality may be explained by improved public awareness regarding suspicious pigmented lesions and the earlier detection of these tumors. Continuation of the current preventive strategy and its expansion to include older age groups in the population are warranted.
(c) 2006 American Cancer Society.
Similar articles
-
Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.Cancer. 2005 Feb 1;103(3):616-24. doi: 10.1002/cncr.20816. Cancer. 2005. PMID: 15630700
-
Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.J Am Acad Dermatol. 2009 Jul;61(1):44-50. doi: 10.1016/j.jaad.2009.01.020. Epub 2009 Apr 23. J Am Acad Dermatol. 2009. PMID: 19395122
-
Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).Br J Dermatol. 2006 Jun;154(6):1123-7. doi: 10.1111/j.1365-2133.2006.07163.x. Br J Dermatol. 2006. PMID: 16704644
-
Cutaneous melanoma.Cancer Surv. 1994;19-20:219-40. Cancer Surv. 1994. PMID: 7534627 Review.
-
[Malignant skin melanoma in Estonia: incidence and survival].Vopr Onkol. 1987;33(9):10-4. Vopr Onkol. 1987. PMID: 3310397 Review. Russian.
Cited by
-
[Molecular heterogeneity of malignant melanomas].Pathologe. 2007 Nov;28(6):474-8. doi: 10.1007/s00292-007-0942-6. Pathologe. 2007. PMID: 17885757 German.
-
Immunotherapy against esophageal primary amelanotic malignant melanoma relapse.J Surg Case Rep. 2021 Oct 13;2021(10):rjab393. doi: 10.1093/jscr/rjab393. eCollection 2021 Oct. J Surg Case Rep. 2021. PMID: 34659737 Free PMC article.
-
Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in Lithuania: an analysis of national cancer registration data by gender and anatomical site, 1991-2015.Contemp Oncol (Pozn). 2022;26(4):289-293. doi: 10.5114/wo.2023.124920. Epub 2022 Dec 30. Contemp Oncol (Pozn). 2022. PMID: 36816395 Free PMC article.
-
Increased CCL17 serum levels are associated with improved survival in advanced melanoma.Cancer Immunol Immunother. 2015 Sep;64(9):1075-82. doi: 10.1007/s00262-015-1714-4. Epub 2015 May 20. Cancer Immunol Immunother. 2015. PMID: 25990074 Free PMC article.
-
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment.Nat Commun. 2023 Jul 20;14(1):4253. doi: 10.1038/s41467-023-39817-3. Nat Commun. 2023. PMID: 37474523 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous